Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03395262 · ClinicalTrials.gov registry record · NA
An Examination of a Weight Loss Formula on Health
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03395262: Completed NA study, sponsored by Texas A&M University.
NCT03395262 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03395262, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
Primary Outcome
Changes in body weight (kg) analyzed with related body composition variables via General Linear Model multivariate and univariate analyses and mean changes from baseline with 95% confidence intervals (CI's).
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Active with caffeine
- DIETARY_SUPPLEMENT Active without caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03395262 record still lists
NCT03395262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03395262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03395262 about?
NCT03395262 is a clinical study titled "An Examination of a Weight Loss Formula on Health". The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
What is the current status of trial NCT03395262?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-06-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03395262?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Active with caffeine (DIETARY_SUPPLEMENT), Active without caffeine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03395262?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03395262's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI